Baxter and Halozyme Announce Collaboration For Development Of ...
Baxter and Halozyme Announce Collaboration For Development Of ...
Baxter and Halozyme Announce Collaboration For Development Of ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Baxter</strong> <strong>and</strong> <strong>Halozyme</strong> <strong>Announce</strong> <strong>Collaboration</strong> <strong>For</strong> <strong>Development</strong> <strong>Of</strong> Su...neous GAMMAGARD LIQUID Administration using Enhanze Technology<br />
from the expectations contained in the forward-looking statements.<br />
HYLENEX recombinant, GAMMAGARD LIQUID <strong>and</strong> KIOVIG are trademarks of <strong>Baxter</strong> Healthcare<br />
Corporation.<br />
Cumulase <strong>and</strong> Enhanze are trademarks of <strong>Halozyme</strong> Therapeutics, Inc.<br />
<strong>For</strong> More Information<br />
Media Contacts<br />
Christopher Bona, (847) 948-2815 - <strong>Baxter</strong><br />
Tarsis Lopez, (847) 940-5166 - <strong>Baxter</strong><br />
Karen Sparks, (858) 455-5500, x275 -<br />
<strong>Halozyme</strong><br />
Investor Contacts<br />
Mary Kay Ladone, (847) 948-3371 - <strong>Baxter</strong><br />
Clare Trachtman, (847) 948-3085 - <strong>Baxter</strong><br />
David A. Ramsay, (858) 794-8881 - <strong>Halozyme</strong><br />
Don Markley, (310) 691-7100 - <strong>Halozyme</strong><br />
Copyright & Legal Disclaimer | Privacy |<br />
Print this page<br />
http://www.baxter.com/about_baxter/news_room/news_releases/2007/09-10-07-baxter_halozyme.html (4 of 4)10/23/2007 10:30:44 AM
Change language